176 related articles for article (PubMed ID: 35744905)
1. Synthesis and Activity of Triazole-Adenosine Analogs as Protein Arginine Methyltransferase 5 Inhibitors.
Brown T; Cao M; Zheng YG
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744905
[TBL] [Abstract][Full Text] [Related]
2. Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity.
Zhu K; Shao J; Tao H; Yan X; Luo C; Zhang H; Duan W
J Comput Aided Mol Des; 2019 Aug; 33(8):775-785. PubMed ID: 31312965
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new potent protein arginine methyltransferase 5 (PRMT5) inhibitors by assembly of key pharmacophores from known inhibitors.
Zhu K; Song JL; Tao HR; Cheng ZQ; Jiang CS; Zhang H
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3693-3699. PubMed ID: 30366617
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel PRMT5 Inhibitors by Virtual Screening and Biological Evaluations.
Tao H; Yan X; Zhu K; Zhang H
Chem Pharm Bull (Tokyo); 2019; 67(4):382-388. PubMed ID: 30930442
[TBL] [Abstract][Full Text] [Related]
5. Interaction assessments of the first S-adenosylmethionine competitive inhibitor and the essential interacting partner methylosome protein 50 with protein arginine methyltransferase 5 by combined computational methods.
Zhu K; Jiang CS; Hu J; Liu X; Yan X; Tao H; Luo C; Zhang H
Biochem Biophys Res Commun; 2018 Jan; 495(1):721-727. PubMed ID: 29154828
[TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of selective inhibitors of protein arginine methyltransferase 5 by docking-based virtual screening.
Ye Y; Zhang B; Mao R; Zhang C; Wang Y; Xing J; Liu YC; Luo X; Ding H; Yang Y; Zhou B; Jiang H; Chen K; Luo C; Zheng M
Org Biomol Chem; 2017 May; 15(17):3648-3661. PubMed ID: 28397890
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel PRMT5 inhibitors bearing a methylpiperazinyl moiety.
Bai X; Zhai Z; Zhao X; Li R; Liang L; Jin Y; Yin Y
Future Med Chem; 2022 Jul; 14(14):1071-1086. PubMed ID: 35748226
[No Abstract] [Full Text] [Related]
8. Identification of a novel selective small-molecule inhibitor of protein arginine methyltransferase 5 (PRMT5) by virtual screening, resynthesis and biological evaluations.
Zhu K; Jiang C; Tao H; Liu J; Zhang H; Luo C
Bioorg Med Chem Lett; 2018 May; 28(9):1476-1483. PubMed ID: 29628326
[TBL] [Abstract][Full Text] [Related]
9. Arginine Methyltransferase 5 (PRMT5) Inhibitors with 3-(1H-benzo[d]imidazol- 2-yl)anilines Core Identified by Virtual Screening and Biological Evaluation.
Zhang Y; Zhu K; Zhang J; Zhang JH; Song Z; Zhang X; Liu SK; Jiang CS
Curr Pharm Des; 2023; 29(6):474-479. PubMed ID: 36790004
[TBL] [Abstract][Full Text] [Related]
10. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
[TBL] [Abstract][Full Text] [Related]
11. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell Lung Cancer.
Chen Y; Zhang M; Wu A; Yao X; Wang Q
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364261
[TBL] [Abstract][Full Text] [Related]
12. Discovery of selective protein arginine methyltransferase 5 inhibitors and biological evaluations.
Ji S; Ma S; Wang WJ; Huang SZ; Wang TQ; Xiang R; Hu YG; Chen Q; Li LL; Yang SY
Chem Biol Drug Des; 2017 Apr; 89(4):585-598. PubMed ID: 27714957
[TBL] [Abstract][Full Text] [Related]
13. Structure-Aided Design, Synthesis, and Biological Evaluation of Potent and Selective Non-Nucleoside Inhibitors Targeting Protein Arginine Methyltransferase 5.
Rong D; Zhou K; Fang W; Yang H; Zhang Y; Shi Q; Huang Y; Li J; Dong H; Li L; Ding J; Huang X; Wang Y
J Med Chem; 2022 Jun; 65(11):7854-7875. PubMed ID: 35612488
[TBL] [Abstract][Full Text] [Related]
14. SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance.
Jensen-Pergakes K; Tatlock J; Maegley KA; McAlpine IJ; McTigue M; Xie T; Dillon CP; Wang Y; Yamazaki S; Spiegel N; Shi M; Nemeth A; Miller N; Hendrickson E; Lam H; Sherrill J; Chung CY; McMillan EA; Bryant SK; Palde P; Braganza J; Brooun A; Deng YL; Goshtasbi V; Kephart SE; Kumpf RA; Liu W; Patman RL; Rui E; Scales S; Tran-Dube M; Wang F; Wythes M; Paul TA
Mol Cancer Ther; 2022 Jan; 21(1):3-15. PubMed ID: 34737197
[TBL] [Abstract][Full Text] [Related]
15. Research Progress on Small-molecule Inhibitors of Protein Arginine Methyltransferase 5 (PRMT5) for Treating Cancer.
Guo C; Wu L; Zheng X; Zhao L; Hou X; Wang Z; Han C
Curr Top Med Chem; 2023; 23(21):2048-2074. PubMed ID: 37438905
[TBL] [Abstract][Full Text] [Related]
16. Exploration of cyanine compounds as selective inhibitors of protein arginine methyltransferases: synthesis and biological evaluation.
Hu H; Owens EA; Su H; Yan L; Levitz A; Zhao X; Henary M; Zheng YG
J Med Chem; 2015 Feb; 58(3):1228-43. PubMed ID: 25559100
[TBL] [Abstract][Full Text] [Related]
17. Structure-based discovery of a new series of nucleoside-derived ring-opening PRMT5 inhibitors.
Chen Y; Wang Z; Zhang J; Shi Q; Yang H; Deng Y; Wang X; Liu T; Geng M; Xiong B; Huang X
Eur J Med Chem; 2024 Mar; 267():116171. PubMed ID: 38301329
[TBL] [Abstract][Full Text] [Related]
18. Development of an AlphaLISA high throughput technique to screen for small molecule inhibitors targeting protein arginine methyltransferases.
Prabhu L; Chen L; Wei H; Demir Ö; Safa A; Zeng L; Amaro RE; O'Neil BH; Zhang ZY; Lu T
Mol Biosyst; 2017 Nov; 13(12):2509-2520. PubMed ID: 29099132
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel PRMT1 inhibitors and investigation of their binding preferences using molecular modelling.
Yang H; Ouyang Y; Ma H; Cong H; Zhuang C; Lok WT; Wang Z; Zhu X; Sun Y; Hong W; Wang H
Bioorg Med Chem Lett; 2017 Oct; 27(20):4635-4642. PubMed ID: 28927791
[TBL] [Abstract][Full Text] [Related]
20. Identification of PRMT5 inhibitors with novel scaffold structures through virtual screening and biological evaluations.
Zhang Q; Zhang L; Jin J; Fan Y; Wang X; Hu H; Ye X; Wang L; Cao C; Ye F
J Mol Model; 2022 Jun; 28(7):184. PubMed ID: 35680707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]